These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10072744)

  • 1. Serum cholesterol trends among members of the Finnish parliament.
    Nikkari ST; Oksa P; Vattulainen K; Kohvakka A; Puska P; Roto P
    Prev Med; 1999 Mar; 28(3):260-3. PubMed ID: 10072744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in serum cholesterol and lifestyle indicators in Members of the Finnish Parliament.
    Kohvakka A; Palmroos P; Koivu TA; Roto P; Uitti J; Sillanaukee P; Alho H; Oksa P; Nikkari ST
    Public Health; 2003 Jan; 117(1):11-4. PubMed ID: 12802899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference.
    Juonala M; Viikari JS; Hutri-Kähönen N; Pietikäinen M; Jokinen E; Taittonen L; Marniemi J; Rönnemaa T; Raitakari OT
    J Intern Med; 2004 Apr; 255(4):457-68. PubMed ID: 15049880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002.
    Arnett DK; Jacobs DR; Luepker RV; Blackburn H; Armstrong C; Claas SA
    Circulation; 2005 Dec; 112(25):3884-91. PubMed ID: 16344385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thickness.
    Watanabe H; Söderlund S; Soro-Paavonen A; Hiukka A; Leinonen E; Alagona C; Salonen R; Tuomainen TP; Ehnholm C; Jauhiainen M; Taskinen MR
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):897-902. PubMed ID: 16469947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary prevention in hypercholesterolemia. High HDL cholesterol levels and female gender underestimated protective factors].
    Wahlberg G
    Lakartidningen; 2006 Jan 18-24; 103(3):131-4. PubMed ID: 16465756
    [No Abstract]   [Full Text] [Related]  

  • 8. High serum total cholesterol--an indicator for monitoring cholesterol lowering efforts: U.S. adults, 2005-2006.
    Schober SE; Carroll MD; Lacher DA; Hirsch R;
    NCHS Data Brief; 2007 Dec; (2):1-8. PubMed ID: 19389314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary heart disease risk factors among blood donors in northwest Ethiopia.
    Gebre-Yohannes A; Rahlenbeck SI
    East Afr Med J; 1998 Sep; 75(9):495-500. PubMed ID: 10493048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2.
    Gupta R; Gupta VP; Sarna M; Bhatnagar S; Thanvi J; Sharma V; Singh AK; Gupta JB; Kaul V
    Indian Heart J; 2002; 54(1):59-66. PubMed ID: 11999090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid levels. Applying the second National Cholesterol Education Program report to geriatric medicine.
    Mormando RM
    Geriatrics; 2000 Aug; 55(8):48-53; quiz 54. PubMed ID: 10953686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between on-treatment increments in serum high-density lipoprotein cholesterol levels and cardiac mortality in patients with coronary heart disease (from the Bezafibrate Infarction Prevention trial).
    Goldenberg I; Goldbourt U; Boyko V; Behar S; Reicher-Reiss H;
    Am J Cardiol; 2006 Feb; 97(4):466-71. PubMed ID: 16461038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cholesterol and coronary heart disease: Auckland general practitioners' attitudes and practices in 1986.
    Yates K; Jackson R; Tester P; Thompson A; Toledo J; Vamanamurthy R; Wong C
    N Z Med J; 1988 Feb; 101(840):76-8. PubMed ID: 3380436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of changes in risk factors to the decline of coronary heart disease mortality in Australia over three decades.
    Taylor R; Dobson A; Mirzaei M
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):760-8. PubMed ID: 17001216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.